Round Of Applause For A Visionary Leader And A Look Back In The Rear View - Pt. 2
Posted: Mon Aug 03, 2020 9:46 am
Round Of Applause For A Visionary Leader And A Look Back In The Rear View - Pt. 2
One of the most significant and meaningful moves by Dr. Scarlett on his road towards approval was the first hire after the J&J CD meltdown. It came with no PR and zero fanfare. The hiring of Damanjit Singh in November, 2018 was a precursor of things to come.
https://www.linkedin.com/in/damanjit-singh/
Damanjit is a GXP Quality Systems manager. What is a GXP Quality Systems manager you may ask……
https://www.cleardata.com/wp-content/up ... _FINAL.pdf
https://gxpqsllc.com/
A GXP Quality Systems manager is crucial in the Regulatory Approval process. Hiring Damanjit a month after such a blow as the J&J CD goes to show the tenacity and vision that Dr. Scarlett has for Imetelstats approval and commercialization. As I’ve said many times before, this is a driven man. While we reflect on the importance of the confirmation of Imets Orphan Drug Designation by the EMA let us remember the man who has made this all possible. In the face of adversity, along with some of the greatest challenges one could imagine he has skillfully created an independent company with a fighting chance to go it alone and bring to market a drug which has the potential of treating multiple indications. It is a proud day indeed for us as investors and patients around the world. Thank you Dr. Scarlett and Team Geron for raising the bar to a level that will benefit us all. -Kmall
One of the most significant and meaningful moves by Dr. Scarlett on his road towards approval was the first hire after the J&J CD meltdown. It came with no PR and zero fanfare. The hiring of Damanjit Singh in November, 2018 was a precursor of things to come.
https://www.linkedin.com/in/damanjit-singh/
Damanjit is a GXP Quality Systems manager. What is a GXP Quality Systems manager you may ask……
https://www.cleardata.com/wp-content/up ... _FINAL.pdf
https://gxpqsllc.com/
A GXP Quality Systems manager is crucial in the Regulatory Approval process. Hiring Damanjit a month after such a blow as the J&J CD goes to show the tenacity and vision that Dr. Scarlett has for Imetelstats approval and commercialization. As I’ve said many times before, this is a driven man. While we reflect on the importance of the confirmation of Imets Orphan Drug Designation by the EMA let us remember the man who has made this all possible. In the face of adversity, along with some of the greatest challenges one could imagine he has skillfully created an independent company with a fighting chance to go it alone and bring to market a drug which has the potential of treating multiple indications. It is a proud day indeed for us as investors and patients around the world. Thank you Dr. Scarlett and Team Geron for raising the bar to a level that will benefit us all. -Kmall